Search Within

Alexander Noor Shoushtari

  1. "Debra Goldman"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (4)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (9)
  2. Biostatistics Service (9)
  3. Department of Medicine (9)
  4. Epidemiology and Biostatistics (9)
  5. GSK Faculty (9)
  6. Hematologic Malignancies, Division of (9)

More Groups

People
  1. Debra Goldman (9)
  2. Jedd Wolchok (9)
  3. Katherine Panageas (9)
  4. Michael Postow (9)
  5. Paul Chapman (9)
  6. Margaret Callahan (8)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (3)
  6. 2019 (1)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Clinical Cancer Research (2)
  3. Melanoma Research (1)
Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (2)
  3. Lippincott Williams & Wilkins (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early on-treatment assessment of T cells, cytokines, and tumor DNA with adaptively dosed nivolumab + ipilimumab: Final results from the phase 2 ADAPT-IT study
    Journal Article

    Smithy, J. W.; Kalvin, H. L.; Ehrich, F. D.; Shah, R.; Adamow, M.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)
    Meeting Abstract

    Smithy, J. W.; Kalvin, H. L.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Adaptive dosing of nivolumab + ipilimumab immunotherapy based upon early, interim radiographic assessment in advanced melanoma (The ADAPT-IT study)
    Journal Article

    Postow, M. A.; Goldman, D. A.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; Smithy, J. W.; Naito, E.; Cugliari, M. K.; Raber, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Characteristics and probability of survival for patients with advanced melanoma who live five or more years after initial treatment with immune checkpoint blockade (ICB)
    Meeting Abstract

    Loo, K.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase II study to evaluate the need for > two doses of nivolumab plus ipilimumab combination (combo) immunotherapy
    Meeting Abstract

    Postow, M. A.; Goldman, D. A.; Shoushtari, A. N.; Warner, A. B.; Callahan, M. K.; Momtaz, P.; Naito, E.; Eton, O.; Nair, S.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A prospective, phase 1 trial of nivolumab, ipilimumab, and radiotherapy in patients with advanced melanoma
    Journal Article

    Postow, M. A.; Knox, S. J.; Goldman, D. A.; Elhanati, Y.; Mavinkurve, V.; Wong, P.; Halpenny, D.; Reddy, S. K.; Vado, K.; McCabe, D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Long-term outcomes and responses to retreatment in patients with melanoma treated with PD-1 blockade
    Journal Article

    Warner, A. B.; Palmer, J. S.; Shoushtari, A. N.; Goldman, D. A.; Panageas, K. S.; Hayes, S. A.; Bajwa, R.; Momtaz, P.; Callahan, M. K.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Responders to anti-PD1 therapy: Long-term outcomes and responses to retreatment in melanoma (mel)
    Meeting Abstract

    Warner, A. B.; Palmer, J. S.; Shoushtari, A. N.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Wolchok, J. D.; Postow, M. A.; Chapman, P. B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma
    Journal Article

    Shoushtari, A. N.; Bluth, M. J.; Goldman, D. A.; Bitas, C.; Lefkowitz, R. A.; Postow, M. A.; Munhoz, R. R.; Buchar, G.; Hester, R. H.; Romero, J. A.; more...
    Melanoma Research (2017)

    Fulltext@MSK | Save